These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 32630477)
1. A Review on Notch Signaling and Colorectal Cancer. Tyagi A; Sharma AK; Damodaran C Cells; 2020 Jun; 9(6):. PubMed ID: 32630477 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic antibody targeting of individual Notch receptors. Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Piazzi G; Bazzoli F; Ricciardiello L Cell Cycle; 2012 Dec; 11(23):4323-7. PubMed ID: 23085543 [TBL] [Abstract][Full Text] [Related]
5. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma. Herrera-Rios D; Li G; Khan D; Tsiampali J; Nickel AC; Aretz P; Hewera M; Suwala AK; Jiang T; Steiger HJ; Kamp MA; Muhammad S; Hänggi D; Maciaczyk J; Zhang W; Kahlert UD Sci Rep; 2020 Oct; 10(1):16218. PubMed ID: 33004830 [TBL] [Abstract][Full Text] [Related]
6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. Hales EC; Taub JW; Matherly LH Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475 [TBL] [Abstract][Full Text] [Related]
7. Recent advances on NOTCH signaling in T-ALL. Tzoneva G; Ferrando AA Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746 [TBL] [Abstract][Full Text] [Related]
8. Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing. Chen J; Zolkiewska A PLoS One; 2011; 6(7):e22837. PubMed ID: 21829530 [TBL] [Abstract][Full Text] [Related]
9. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Tosello V; Ferrando AA Ther Adv Hematol; 2013 Jun; 4(3):199-210. PubMed ID: 23730497 [TBL] [Abstract][Full Text] [Related]
10. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. Berezovska O; Jack C; McLean P; Aster JC; Hicks C; Xia W; Wolfe MS; Kimberly WT; Weinmaster G; Selkoe DJ; Hyman BT J Neurochem; 2000 Aug; 75(2):583-93. PubMed ID: 10899933 [TBL] [Abstract][Full Text] [Related]
11. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. Das I; Craig C; Funahashi Y; Jung KM; Kim TW; Byers R; Weng AP; Kutok JL; Aster JC; Kitajewski J J Biol Chem; 2004 Jul; 279(29):30771-80. PubMed ID: 15123653 [TBL] [Abstract][Full Text] [Related]
12. Significance of NOTCH1 Expression in the Progression of Human Lung and Colorectal Cancers. Vasileva MV; Khromova NV; Kopnin BP; Dugina VB; Kopnin PB Biochemistry (Mosc); 2022 Oct; 87(10):1199-1205. PubMed ID: 36273888 [TBL] [Abstract][Full Text] [Related]
13. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116. Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602 [TBL] [Abstract][Full Text] [Related]
14. The Notch pathway in colorectal cancer. Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352 [TBL] [Abstract][Full Text] [Related]
15. Notch-Targeted Therapeutic in Colorectal Cancer by Notch1 Attenuation Via Tumor Microenvironment-Responsive Cascade DNA Delivery. Lu Y; Cao Y; Guo X; Gao Y; Chen X; Zhang Z; Ge Z; Chu D Adv Healthc Mater; 2024 Sep; 13(22):e2400797. PubMed ID: 38726796 [TBL] [Abstract][Full Text] [Related]
16. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Shih IeM; Wang TL Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312 [TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase inhibitor, a potential target therapy for MUC2-positive colorectal carcinoma. Bu X; Li N; Tian X; Huang P Neoplasma; 2011; 58(4):343-7. PubMed ID: 21520992 [TBL] [Abstract][Full Text] [Related]
18. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Takebe N; Nguyen D; Yang SX Pharmacol Ther; 2014 Feb; 141(2):140-9. PubMed ID: 24076266 [TBL] [Abstract][Full Text] [Related]
19. Role of Notch signaling in colorectal cancer. Qiao L; Wong BC Carcinogenesis; 2009 Dec; 30(12):1979-86. PubMed ID: 19793799 [TBL] [Abstract][Full Text] [Related]
20. Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer. Fender AW; Nutter JM; Fitzgerald TL; Bertrand FE; Sigounas G J Cell Biochem; 2015 Nov; 116(11):2517-27. PubMed ID: 25914224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]